United States · FDA National Drug Code directory
Pregabalin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 47335-690_52bb3d43-24c1-4789-8423-6c2d54850e75
- Product NDC
- 47335-690
- Form
- CAPSULE
- Composition / generic term
- Pregabalin
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20191204
- Source listing expiry
- 20261231
Source-listed ingredients
- PREGABALIN — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (47335-690-08) · 47335-690-08
- 1000 CAPSULE in 1 BOTTLE (47335-690-18) · 47335-690-18
- 30 CAPSULE in 1 BOTTLE (47335-690-83) · 47335-690-83
- 100 CAPSULE in 1 BOTTLE (47335-690-88) · 47335-690-88
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →